comparemela.com
  1. Home
  2. Live Updates
  3. Infocus Clinical - Breaking News

Latest Breaking News On - Infocus clinical - Page 1 : comparemela.com

Endogena Therapeutics Completes Enrollment Ahead of Schedule in its Phase 1/2a Trial of EA-2353 for Retinitis Pigmentosa

Endogena Therapeutics Completes Enrollment Ahead of Schedule in its Phase 1/2a Trial of EA-2353 for Retinitis Pigmentosa
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesMatthias stegerEndogena therapeutics incInfocus clinical researchFree range communicationsTherapeutics incEndogena therapeuticsInfocus clinicalOrphan drug designationFast track designationOrange communications

Endogena finalises enrolment for retinitis pigmentosa trial

The treatment is a small molecule that activates endogenous retinal stem and progenitor cells - News - PharmaTimes

Matthias stegerInfocus clinical researchEndogena therapeuticsInfocus clinical

Endogena Therapeutics Completes Enrollment Ahead of Schedule in its Phase 1/2a Trial of EA-2353 for Retinitis Pigmentosa

Endogena Therapeutics Completes Enrollment Ahead of Schedule in its Phase 1/2a Trial of EA-2353 for Retinitis Pigmentosa

United statesSan franciscoMatthias stegerInfocus clinical researchEndogena therapeutics incTherapeutics incEndogena therapeuticsInfocus clinical

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.